{"gene":"ALX4","run_date":"2026-06-09T22:02:43","timeline":{"discoveries":[{"year":1997,"finding":"ALX4 (Alx-4) encodes a paired-type homeodomain protein expressed in anterior limb bud mesenchyme; homozygous null mice develop preaxial polydactyly associated with ectopic anterior ZPA formation, as shown by anterior expression of Sonic hedgehog, HoxD13, and FGF-4, establishing ALX4 as a determinant of anterior-posterior positional identity that restricts ZPA formation to the posterior limb bud mesenchyme.","method":"Targeted gene disruption (knockout mice), whole-mount in situ hybridization for Shh, HoxD13, FGF-4, HoxB8, Gli3; chromosomal mapping","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean KO with defined cellular phenotype, multiple molecular markers, independently corroborated by other labs","pmids":["9374397"],"is_preprint":false},{"year":1997,"finding":"Alx4 protein is found in nuclear extracts of mouse embryos, consistent with its function as a transcription factor; Northern blot and whole-mount in situ hybridization localize Alx4 expression to craniofacial mesenchyme, first branchial arch, and limb bud during development.","method":"Northern blot, whole-mount in situ hybridization, immunoblot of nuclear extracts with anti-Alx4 antibodies","journal":"Gene","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — direct nuclear localization by fractionation with antibody detection, multiple methods in single lab","pmids":["9426253"],"is_preprint":false},{"year":1997,"finding":"Genetic interaction between Bmp4, Gli3, and Alx4 in anterior digit patterning: double heterozygotes of Bmp4 and Alx4 null alleles display ectopic anterior digits specifically on hindlimbs, placing Alx4 downstream or in parallel with Bmp4 signaling in a multigenic control network for anterior digit formation.","method":"Genetic epistasis — double heterozygous mutant mice (Bmp4+/-; Alx4+/-), phenotypic analysis","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean genetic epistasis in double mutant mice, single lab","pmids":["9268572"],"is_preprint":false},{"year":1998,"finding":"A 16 bp deletion in the homeobox region of Alx-4 in Strong's Luxoid (lstJ) mice causes a frameshift and protein truncation, identifying this as the causative mutation for polydactyly in lstJ mice; chick Alx-4 expression is complementary to Shh, and Shh/FGF application suppresses Alx-4 expression while AER removal experiments indicate a negative feedback loop between Alx-4 and Shh during limb outgrowth, independent of Gli3.","method":"Sequence analysis of lstJ allele, chick Alx-4 cloning, bead implantation (Shh/FGF protein application), AER removal surgery, in situ hybridization in polydactylous mutants","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal experimental approaches (mutation identification, protein application, surgical manipulation, mutant analysis) in single study, replicated conceptually across labs","pmids":["9778501"],"is_preprint":false},{"year":1998,"finding":"Alx-4 is a potent transcriptional activator when expressed in cell culture; optimal transcriptional activation requires specific sequences in the N-terminal region and a proline-rich domain downstream of the paired-like homeodomain, but not the paired-tail (C terminus). Alx-4 is expressed in mesenchymal condensations at sites of epithelial-mesenchymal interaction (osteoblast precursors, dermal papilla of hair/whisker follicles, dental papilla, mammary gland mesenchyme).","method":"Reporter gene (transcriptional activation) assays in cell culture with deletion constructs; whole-mount in situ hybridization; immunofluorescence","journal":"Developmental dynamics : an official publication of the American Association of Anatomists","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reporter assay with domain deletion mutants in cell culture, single lab, multiple deletion constructs tested","pmids":["9786416"],"is_preprint":false},{"year":1999,"finding":"ALX4 and Cart1 (paired-type homeodomain proteins) form DNA-binding heterodimers in vitro with similar binding activity to palindromic elements; they similarly activate transcription from reporter genes containing high-affinity binding sites in cell culture; double mutant mice show additive/exacerbated craniofacial and limb defects (polydactyly, nasal cartilage fusion failure, split sternum), demonstrating functional redundancy and both unique and shared developmental roles.","method":"In vitro DNA binding assay, co-immunoprecipitation/gel-shift (heterodimer formation), reporter gene assay in cell culture, double mutant mouse genetic analysis","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — in vitro reconstitution of heterodimer DNA binding combined with reporter assay and epistatic double-mutant analysis","pmids":["9847249"],"is_preprint":false},{"year":2001,"finding":"Alx4 physically interacts with LEF-1 through a proline-rich domain in the N-terminal region of Alx4 and the HMG-box DNA-binding domain of LEF-1; ALX4 and LEF-1 can bind simultaneously to adjacent sites on the N-CAM promoter, altering N-CAM promoter activity; expression of Alx4 in primary mammary stromal cells decreases endogenous N-CAM protein levels.","method":"Co-immunoprecipitation, domain deletion mutants, reporter gene assay on N-CAM promoter, immunoblot of endogenous N-CAM in primary cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal interaction mapped by domain deletions, functional reporter assay, endogenous protein effect confirmed in primary cells, multiple orthogonal methods","pmids":["11696550"],"is_preprint":false},{"year":2001,"finding":"Alx3/Alx4 double mutant mice develop severe nasal clefting and craniofacial defects absent in single mutants; increased apoptosis localized to the frontonasal process in E10.0 double mutants establishes that Alx3 and Alx4 cooperate to suppress apoptosis in outgrowing frontonasal mesenchyme, with functional redundancy in craniofacial development.","method":"Generation of Alx3 null (lacZ knock-in) and double mutant mice, histological and anatomical analysis, TUNEL apoptosis assay","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean double KO with defined apoptotic phenotype localized spatiotemporally, multiple methods","pmids":["11641221"],"is_preprint":false},{"year":2001,"finding":"Haploinsufficiency of ALX4 (a paired-related homeodomain transcription factor at 11p11-p12) causes parietal foramina (skull ossification defects) in humans, establishing ALX4 as a dosage-sensitive regulator of calvarial bone formation.","method":"Mutation analysis in human patients with parietal foramina; identification of loss-of-function mutations in ALX4; FISH mapping of 11p11.2 deletions","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — human genetic loss-of-function with consistent phenotype, replicated across multiple families and two independent studies (PMID 11137991, 11106354, 11017806)","pmids":["11137991","11106354","11017806"],"is_preprint":false},{"year":2003,"finding":"Foxc1 regulates BMP-mediated induction of Alx4 (and Msx2) in calvarial mesenchyme; BMP induces Alx4 expression in this tissue, and this induction requires the forkhead transcription factor Foxc1; loss of Foxc1 reduces Alx4 and Msx2 expression and impairs osteoprogenitor cell proliferation.","method":"Analysis of ch (Foxc1 null) mutant mice, BMP bead implantation, in situ hybridization, BrdU proliferation assay","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function mouse with defined molecular readout, BMP bead gain-of-function, single lab","pmids":["14512019"],"is_preprint":false},{"year":2004,"finding":"Alx4 and Msx2 are partially functionally redundant in skull vault ossification; incremental loss of alleles causes additive exacerbation of skull defects; in Msx2 null mice, Alx4 expression is decreased (but not abolished) in the coronal suture region, and vice versa, indicating mutual regulation; expression of Fgfr1 and Fgfr2 (but not Twist1 or Runx2) is reduced in both single mutants, placing them upstream of Fgfr signaling in the osteogenic network.","method":"Alx4/Msx2 double mutant mouse generation and compound genotype analysis, in situ hybridization for multiple markers, alkaline phosphatase staining","journal":"Journal of anatomy","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — double mutant epistasis with multiple molecular markers, single lab","pmids":["15198690"],"is_preprint":false},{"year":2005,"finding":"In Alx4 null limb buds, anterior ectopic expression of Fgf4 and Hoxd13 occurs independently of SHH signaling at early stages, while later polydactyly requires SHH; Gli3-dependent and Gli3-independent modules control Alx4 expression in the limb bud (total absence of reporter in Gli3-/- background; expansion in Shh-/- background), and loss of the severe polydactyly in Gli3-/-;Alx4-/- double mutants shows that this polydactyly requires Alx4 function.","method":"Alx4/Gli3 double mutant analysis, reporter construct expression analysis in Shh-/- and Gli3-/- backgrounds, in situ hybridization","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — epistasis with multiple single and double mutants, reporter construct analysis, multiple orthogonal methods, consistent with independent study (PMID 15968591)","pmids":["16039644","15968591"],"is_preprint":false},{"year":2006,"finding":"Alx4 is expressed in mammary stromal cells adjacent to terminal end buds during puberty; its expression is induced by 17β-estradiol in stromal cells; loss of Alx4 causes defective ductal morphogenesis (delayed development, distorted duct size, reduced branching). The morphogenic defect is stromal-cell-autonomous: Alx4-deficient stromal cells combined with wild-type epithelial cells recapitulate the defect, but wild-type stromal cells rescue Alx4-deficient epithelial cells. MMP2 is increased 40% and MMP9 decreased 50% in Alx4-deficient mammary stromal cells.","method":"Alx4 null mouse analysis, mammary fat pad transplantation (stromal/epithelial mixing experiments), whole-mount analysis, RT-PCR for HGF/MMP2/MMP3/MMP9","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — cell-autonomous stromal function established by fat pad transplantation (reconstitution experiment), multiple molecular readouts, single lab with rigorous cell-mixing design","pmids":["16916507"],"is_preprint":false},{"year":2006,"finding":"Genetic interaction between Lef1 and Alx4 is required for early embryonic development; compound Lef1-/-/Alx4lstD/lstD double mutant mice die by E9.5 (whereas single mutants survive), with defective vasculogenesis in embryonic and extraembryonic tissues, genetically confirming the in vitro Alx4–LEF-1 interaction.","method":"Double mutant mouse generation (Lef1-/-/Alx4lstD/lstD), embryo analysis, PECAM staining for vasculature","journal":"The International journal of developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic confirmation of biochemical interaction with defined lethal phenotype, single lab","pmids":["16892173"],"is_preprint":false},{"year":2009,"finding":"A homozygous nonsense mutation in ALX4 (p.R265X) truncating the homeodomain and paired-tail domain produces a non-functional protein (mRNA is stable; no NMD); in patient skin, there is a hypomorphic interfollicular epidermis with reduced suprabasal layers, impaired interfollicular epidermal differentiation, and altered hair follicle differentiation, establishing ALX4 as required for craniofacial, skin, and hair follicle development.","method":"Homozygosity mapping, mutation identification, RT-PCR (NMD testing), skin biopsy histology and differentiation marker analysis","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — human loss-of-function with direct tissue analysis of downstream molecular phenotype, single family","pmids":["19692347"],"is_preprint":false},{"year":2014,"finding":"NMR solution structures of the ALX4 homeodomain were determined, providing structural coverage of the DNA-binding domain.","method":"Solution NMR structure determination","journal":"Journal of structural and functional genomics","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — NMR structure solved but no functional validation in same study","pmids":["24941917"],"is_preprint":false},{"year":2015,"finding":"HOXB13 and ALX4 form a protein complex in ovarian cancer cells; exogenous expression of either promotes EMT and invasion, while depletion suppresses invasion and reverses EMT; both HOXB13 and ALX4 promote SLUG expression, and SLUG is required for their pro-EMT and pro-invasion effects.","method":"Co-immunoprecipitation (complex formation), overexpression and siRNA knockdown, invasion assays, SLUG knockdown rescue experiments, immunoblot","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP for complex, loss- and gain-of-function with epistatic rescue using SLUG knockdown, single lab","pmids":["25944620"],"is_preprint":false},{"year":2017,"finding":"ALX4 suppresses the Wnt/β-catenin pathway by promoting GSK3β-dependent phosphorylation and degradation of β-catenin in breast cancer cells; ectopic ALX4 expression inhibits cell proliferation and metastasis in vitro and in vivo.","method":"Luciferase reporter assay (Wnt/β-catenin), Western blot for phospho-β-catenin/total β-catenin, overexpression in cancer cell lines, nude mouse xenograft","journal":"Journal of experimental & clinical cancer research : CR","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reporter assay plus phosphorylation western blot, in vivo validation, single lab","pmids":["29183346"],"is_preprint":false},{"year":2017,"finding":"Alx4 directly controls Fgf10 expression in periocular mesenchyme by binding a conserved intronic enhancer element of Fgf10 (conserved in terrestrial but not aquatic animals); Alx4 expression in the neural crest requires Shp2-mediated FGF signaling; loss of Alx4/ALX4 causes lacrimal gland aplasia in mouse and human, positioning Alx4 as a relay in an FGF-Shp2-FGF signaling cascade.","method":"ChIP/reporter assay (Alx4 binding to Fgf10 intronic element), conditional knockout mice (Shp2 in neural crest), in situ hybridization, human patient genetic analysis","journal":"PLoS genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct binding to Fgf10 enhancer element shown, conditional KO, conservation analysis, human genetic validation, multiple orthogonal methods","pmids":["29028795"],"is_preprint":false},{"year":2015,"finding":"Loss of Alx4 causes reduced Fgf10 expression in eyelid mesenchyme and failure of eyelid fusion in mice; reduced Fgf10 is accompanied by a decreased number of periderm cells expressing phospho-c-Jun, establishing that Alx4 regulates eyelid fusion through control of Fgf10 expression.","method":"Novel Alx4 spontaneous allele characterization, in situ hybridization for Fgf10, immunostaining for phospho-c-Jun in periderm","journal":"Mammalian genome : official journal of the International Mammalian Genome Society","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function with defined molecular readout (Fgf10 and phospho-c-Jun), single lab","pmids":["25673119"],"is_preprint":false},{"year":2023,"finding":"A frameshift insertion in ALX4 (c.985_986insGTGC, p.Pro329Argfs*115) that elongates the protein tail domain causes dominant frontonasal dysplasia with ectodermal defects; using a reporter assay, the elongated ALX4 protein shows increased transcriptional activity (gain-of-function); patient keratinocytes show altered expression of Wnt/β-catenin pathway genes, consistent with ALX4 negatively regulating this pathway.","method":"Whole-exome sequencing, reporter assay for ALX4 transcriptional activity, Wnt/β-catenin target gene expression in patient keratinocytes","journal":"American journal of medical genetics. Part A","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reporter assay showing gain-of-function, patient cell molecular analysis, single family","pmids":["37724761"],"is_preprint":false},{"year":2024,"finding":"Crystal/structural analysis of the ALX4 dimer reveals that ALX4 binds a TAAT-NNN-ATTA palindromic dimer site; seven residues participate in dimer binding (conserved across Paired-like family but not other homeodomain proteins); the two ALX4 molecules within the dimer use distinct residues to form asymmetric protein-protein and protein-DNA contacts; ALX4 cooperativity (dimerization) is required for transcriptional activation; disease variants cause distinct molecular defects including loss of cooperativity; ALX4 binds this motif independently of TWIST1 in cranial neural crest cells.","method":"Protein structure determination (crystal/cryo), in vitro DNA binding assays with mutant ALX4 variants, reporter gene assay in cranial neural crest cells, active-site mutagenesis","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 / Strong — structure solved with functional validation (mutagenesis, reporter assay, disease variant stratification), multiple orthogonal methods in single rigorous study","pmids":["40410151"],"is_preprint":false},{"year":2024,"finding":"Tissue-specific Cre-mediated inactivation of Alx4 in cranial neural crest recapitulates craniofacial defects of Alx4-null mice; Alx4 inactivation in cranial neural crest causes restricted hair loss over anterior skull, while inactivation in cranial mesoderm does not affect hair, revealing that Alx4 plays partly redundant roles in multiple lineages during hair follicle development.","method":"Conditional knockout mice (Alx4f/f with lineage-specific Cre lines for neural crest and cranial mesoderm), phenotypic analysis","journal":"Developmental dynamics : an official publication of the American Association of Anatomists","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO in defined lineages with specific phenotypic readout, single lab","pmids":["38481039"],"is_preprint":false},{"year":2013,"finding":"Alx4 is required for normal genital tubercle (GT) development; Alx4 loss-of-function (Alx4Lst/Lst) results in hypoplasia of the dorsal GT and reduced Fibronectin expression; cell migration from infra-umbilical mesenchyme toward the dorsal GT is impaired; augmented Hh signaling-related gene expression in Alx4 mutants, and combinatorial mutant analysis places Alx4 in a genetic interaction with Shh and Gli3 during GT formation.","method":"Alx4Lst/Lst mutant and combinatorial mutant analysis (with Shh, Gli3), tissue labeling for cell migration, in situ hybridization for Hh pathway genes, immunostaining for Fibronectin","journal":"European journal of human genetics : EJHG","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis with multiple combinatorial mutants, cell migration labeling, molecular readout, single lab","pmids":["23942202"],"is_preprint":false}],"current_model":"ALX4 is a paired-like homeodomain transcription factor that forms cooperative homodimers (and heterodimers with Cart1/ALX3) binding palindromic TAAT-NNN-ATTA DNA motifs through asymmetric protein-protein and protein-DNA contacts; it activates transcription via N-terminal proline-rich and homeodomain sequences, physically interacts with LEF-1 to regulate target promoters such as N-CAM, directly binds an Fgf10 intronic enhancer to control lacrimal gland and eyelid development downstream of FGF-Shp2 signaling, suppresses the Wnt/β-catenin pathway through GSK3β-dependent β-catenin degradation, and restricts Sonic hedgehog/ZPA activity to the posterior limb bud mesenchyme through a negative feedback loop with Shh—with haploinsufficiency causing parietal foramina and biallelic loss causing frontonasal dysplasia, alopecia, and craniofacial defects in humans."},"narrative":{"mechanistic_narrative":"ALX4 is a paired-like homeodomain transcription factor that controls anterior–posterior patterning and morphogenesis of the developing limb, craniofacial skeleton, skin, and glandular tissues by regulating mesenchymal gene expression [PMID:9374397, PMID:9786416]. As a nuclear transcriptional activator, it acts through N-terminal and proline-rich sequences flanking its homeodomain, while the paired-tail is dispensable for activation [PMID:9426253, PMID:9786416]. DNA binding is cooperative: ALX4 engages a palindromic TAAT-NNN-ATTA dimer site, with the two molecules making asymmetric protein–protein and protein–DNA contacts, and this dimerization is required for transcriptional activation [PMID:40410151]; it also forms DNA-binding heterodimers with the related factor Cart1 that share target sites and developmental roles [PMID:9847249]. ALX4 partners with LEF-1 through its N-terminal proline-rich region, co-occupies adjacent sites on the N-CAM promoter, and represses N-CAM, a functional interaction genetically required for embryonic vasculogenesis [PMID:11696550, PMID:16892173]. In the limb bud, Alx4 is expressed in anterior mesenchyme and restricts ectopic posterior signaling: its loss causes anterior ectopic Shh, Fgf4, and Hoxd13 expression and preaxial polydactyly, operating in a negative-feedback relationship with Shh and through both Gli3-dependent and Gli3-independent modules [PMID:9374397, PMID:9778501, PMID:16039644, PMID:15968591]. ALX4 sits within BMP- and FGF-driven signaling networks—its calvarial expression is induced by BMP via Foxc1 and is partially redundant with Msx2 upstream of Fgfr signaling [PMID:14512019, PMID:15198690]—and it relays FGF-Shp2 signaling by directly binding a conserved Fgf10 intronic enhancer to drive lacrimal gland and eyelid development [PMID:29028795, PMID:25673119]. ALX4 additionally suppresses Wnt/β-catenin signaling by promoting GSK3β-dependent β-catenin phosphorylation and degradation [PMID:29183346, PMID:37724761]. In humans, ALX4 haploinsufficiency causes parietal foramina, while biallelic loss-of-function and gain-of-function frameshift alleles cause frontonasal dysplasia with skin, hair, and craniofacial defects [PMID:11137991, PMID:11106354, PMID:11017806, PMID:19692347, PMID:37724761].","teleology":[{"year":1997,"claim":"Established ALX4 as a determinant of limb anterior–posterior identity, answering whether an anterior mesenchymal homeodomain factor restricts posterior signaling-center formation.","evidence":"Targeted knockout mice with molecular marker in situ hybridization (Shh, HoxD13, FGF-4)","pmids":["9374397"],"confidence":"High","gaps":["Direct transcriptional targets in limb not identified","Mechanism of ZPA restriction not resolved at molecular level"]},{"year":1997,"claim":"Confirmed nuclear localization and developmental expression domains, supporting a transcription factor role across craniofacial and limb mesenchyme.","evidence":"Nuclear extract immunoblot, Northern blot, whole-mount in situ hybridization in mouse embryos","pmids":["9426253"],"confidence":"Medium","gaps":["No target genes identified","No DNA-binding specificity defined at this stage"]},{"year":1997,"claim":"Placed Alx4 within a multigenic anterior digit-patterning network downstream of or parallel to BMP signaling.","evidence":"Bmp4/Alx4 double heterozygous mouse genetic epistasis","pmids":["9268572"],"confidence":"Medium","gaps":["Biochemical link between Bmp4 and Alx4 not defined","Direction of regulation (downstream vs parallel) unresolved"]},{"year":1998,"claim":"Defined the negative feedback loop between Alx4 and Shh in limb outgrowth and identified the causative lstJ mutation, distinguishing the feedback from Gli3 control.","evidence":"lstJ allele sequencing, chick Shh/FGF bead implantation, AER removal surgery, in situ hybridization","pmids":["9778501"],"confidence":"High","gaps":["Molecular mediators of Shh suppression of Alx4 unknown","Whether feedback is direct or indirect not established"]},{"year":1998,"claim":"Mapped the transcriptional activation determinants of ALX4 to the N-terminal and proline-rich regions, clarifying domain architecture for activator function.","evidence":"Reporter assays with deletion constructs in cell culture; expression analysis at epithelial–mesenchymal interfaces","pmids":["9786416"],"confidence":"Medium","gaps":["Coactivators recruited by N-terminal/proline-rich domains not identified","Native target promoters not tested"]},{"year":1999,"claim":"Demonstrated ALX4–Cart1 heterodimer formation and shared DNA-binding/activation properties, with double mutants revealing functional redundancy in craniofacial and limb development.","evidence":"In vitro DNA binding, gel-shift/Co-IP, reporter assays, double mutant mouse analysis","pmids":["9847249"],"confidence":"High","gaps":["In vivo distribution of homo- vs heterodimers unknown","Distinct vs shared target genes not enumerated"]},{"year":2001,"claim":"Identified LEF-1 as a direct ALX4 partner and N-CAM as a regulated target, linking ALX4 to promoter co-occupancy and gene repression.","evidence":"Co-IP with domain mapping, N-CAM promoter reporter, endogenous N-CAM immunoblot in primary stromal cells","pmids":["11696550"],"confidence":"High","gaps":["Whether the interaction modulates Wnt signaling at this stage not addressed","Genome-wide co-targets unknown"]},{"year":2001,"claim":"Showed Alx3/Alx4 cooperate to suppress apoptosis in frontonasal mesenchyme, establishing redundancy in craniofacial outgrowth.","evidence":"Alx3 null and Alx3/Alx4 double mutant mice, histology, TUNEL assay","pmids":["11641221"],"confidence":"High","gaps":["Pro-survival target genes not identified","Mechanism linking ALX factors to apoptosis suppression unknown"]},{"year":2001,"claim":"Established ALX4 as a dosage-sensitive human gene, with haploinsufficiency causing parietal foramina.","evidence":"Human mutation analysis, loss-of-function identification, FISH mapping across multiple families","pmids":["11137991","11106354","11017806"],"confidence":"High","gaps":["Calvarial target genes not identified","Threshold for dosage sensitivity not defined"]},{"year":2003,"claim":"Positioned Alx4 downstream of BMP and Foxc1 in calvarial osteoprogenitor induction.","evidence":"Foxc1 null mice, BMP bead implantation, in situ hybridization, BrdU assay","pmids":["14512019"],"confidence":"Medium","gaps":["Whether Foxc1 directly regulates the Alx4 promoter not shown","Direct BMP-responsive elements not mapped"]},{"year":2004,"claim":"Defined partial redundancy and mutual regulation between Alx4 and Msx2, placing them upstream of Fgfr signaling in skull ossification.","evidence":"Alx4/Msx2 compound mutant mice, multi-marker in situ hybridization, alkaline phosphatase staining","pmids":["15198690"],"confidence":"Medium","gaps":["Direct vs indirect mutual regulation unresolved","Whether Fgfr1/2 are direct targets not established"]},{"year":2005,"claim":"Dissected Gli3-dependent and Gli3-independent control of Alx4, showing early ectopic Fgf4/Hoxd13 is SHH-independent while polydactyly requires Alx4.","evidence":"Alx4/Gli3 double mutants, reporter analysis in Shh-/- and Gli3-/- backgrounds, in situ hybridization","pmids":["16039644","15968591"],"confidence":"High","gaps":["Enhancer elements mediating Gli3-dependent control not mapped","Mechanism of SHH-independent ectopic gene expression unknown"]},{"year":2006,"claim":"Established a stromal-cell-autonomous role for Alx4 in mammary ductal morphogenesis, induced by estradiol and linked to MMP balance.","evidence":"Alx4 null analysis, fat pad transplantation/cell mixing, RT-PCR for MMPs/HGF","pmids":["16916507"],"confidence":"High","gaps":["Whether MMP2/MMP9 are direct transcriptional targets unknown","Estradiol-to-Alx4 induction mechanism not defined"]},{"year":2006,"claim":"Genetically validated the Alx4–LEF-1 interaction in vivo, showing it is required for embryonic vasculogenesis.","evidence":"Lef1-/-/Alx4lstD/lstD double mutant embryos, PECAM staining","pmids":["16892173"],"confidence":"Medium","gaps":["Vascular target genes of the Alx4–LEF-1 complex not identified","Cell type driving the vascular defect not pinpointed"]},{"year":2009,"claim":"Linked biallelic ALX4 loss to a broader human phenotype including skin and hair follicle defects, defining tissue-level requirements.","evidence":"Homozygosity mapping, p.R265X mutation identification, NMD testing, skin biopsy differentiation analysis","pmids":["19692347"],"confidence":"Medium","gaps":["Epidermal target genes not identified","Single family limits genotype–phenotype generalization"]},{"year":2013,"claim":"Extended Alx4 function to genital tubercle development, linking it to Fibronectin-dependent cell migration and Hh/Gli3 interaction.","evidence":"Alx4Lst/Lst and combinatorial mutants, cell migration labeling, Fibronectin immunostaining, Hh-pathway in situ","pmids":["23942202"],"confidence":"Medium","gaps":["Whether Fibronectin is a direct target unknown","Mechanism of migration control not defined"]},{"year":2015,"claim":"Identified Fgf10 as the effector through which Alx4 controls eyelid fusion, connecting it to periderm phospho-c-Jun signaling.","evidence":"Spontaneous Alx4 allele, Fgf10 in situ hybridization, phospho-c-Jun immunostaining","pmids":["25673119"],"confidence":"Medium","gaps":["Direct binding to Fgf10 regulatory elements not shown in this study","Link to phospho-c-Jun mechanistically indirect"]},{"year":2015,"claim":"Revealed an oncogenic context where ALX4 complexes with HOXB13 to drive EMT and invasion via SLUG.","evidence":"Co-IP, overexpression/siRNA, invasion assays, SLUG knockdown rescue in ovarian cancer cells","pmids":["25944620"],"confidence":"Medium","gaps":["Whether SLUG is a direct ALX4/HOXB13 target not shown","Reciprocal Co-IP validation not described"]},{"year":2017,"claim":"Demonstrated direct ALX4 binding to a conserved Fgf10 intronic enhancer downstream of FGF-Shp2 signaling, defining ALX4 as a signaling relay for lacrimal gland development.","evidence":"ChIP/reporter assay, neural-crest Shp2 conditional knockout, in situ hybridization, human genetic analysis","pmids":["29028795"],"confidence":"High","gaps":["Other direct enhancer targets not catalogued","Cofactors at the Fgf10 enhancer not identified"]},{"year":2017,"claim":"Defined ALX4 as a suppressor of Wnt/β-catenin signaling via GSK3β-dependent β-catenin degradation, with tumor-suppressive consequences.","evidence":"Wnt reporter assay, phospho-β-catenin western blot, overexpression, nude mouse xenograft","pmids":["29183346"],"confidence":"Medium","gaps":["Mechanism by which a transcription factor promotes GSK3β-dependent degradation not resolved","Direct vs indirect effect on the destruction complex unknown"]},{"year":2023,"claim":"Identified a gain-of-function tail-elongating frameshift causing dominant frontonasal dysplasia and confirmed ALX4 negatively regulates Wnt/β-catenin in patient cells.","evidence":"Whole-exome sequencing, transcriptional reporter assay, Wnt target gene expression in patient keratinocytes","pmids":["37724761"],"confidence":"Medium","gaps":["Mechanism of tail-domain-driven hyperactivation not defined","Single family limits generalization"]},{"year":2024,"claim":"Resolved the structural basis of cooperative ALX4 dimer binding to the TAAT-NNN-ATTA palindrome and showed dimerization is required for activation, stratifying disease variants by molecular defect.","evidence":"Protein structure determination, mutant in vitro DNA binding, reporter assays in cranial neural crest cells, mutagenesis","pmids":["40410151"],"confidence":"High","gaps":["In vivo genome-wide binding map not established","Functional consequences of each disease variant not tested in animals"]},{"year":2024,"claim":"Used lineage-specific inactivation to assign ALX4 craniofacial and hair phenotypes primarily to cranial neural crest, revealing partly redundant roles across lineages.","evidence":"Conditional Alx4 knockout with neural crest and cranial mesoderm Cre lines, phenotypic analysis","pmids":["38481039"],"confidence":"Medium","gaps":["Lineage-specific target genes not identified","Redundant factors in each lineage not defined"]},{"year":null,"claim":"The genome-wide direct target repertoire of ALX4 and the molecular basis by which it links DNA-binding to Wnt destruction-complex activity and FGF/SHH feedback remain unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No comprehensive in vivo ChIP-seq target map","Mechanism connecting ALX4 to GSK3β-dependent β-catenin degradation undefined","How dimer cooperativity is tuned by partners (LEF-1, Cart1, HOXB13) across tissues unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,4,5,21]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[5,21,18]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[1]}],"pathway":[{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[0,7,18,22]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[4,6,21]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[3,11,17,18]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[8,14,20]}],"complexes":[],"partners":["CART1","LEF1","HOXB13"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9H161","full_name":"Homeobox protein aristaless-like 4","aliases":[],"length_aa":411,"mass_kda":44.2,"function":"Transcription factor involved in skull and limb development. Plays an essential role in craniofacial development, skin and hair follicle development","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q9H161/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ALX4","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/ALX4","total_profiled":1310},"omim":[{"mim_id":"615529","title":"CRANIOSYNOSTOSIS 5, SUSCEPTIBILITY TO; CRS5","url":"https://www.omim.org/entry/615529"},{"mim_id":"613451","title":"FRONTONASAL DYSPLASIA 2; FND2","url":"https://www.omim.org/entry/613451"},{"mim_id":"611145","title":"SOLUTE CARRIER FAMILY 30 (ZINC TRANSPORTER), MEMBER 8; SLC30A8","url":"https://www.omim.org/entry/611145"},{"mim_id":"609945","title":"BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA","url":"https://www.omim.org/entry/609945"},{"mim_id":"609597","title":"PARIETAL FORAMINA 2; PFM2","url":"https://www.omim.org/entry/609597"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"breast","ntpm":1.7},{"tissue":"choroid plexus","ntpm":1.5}],"url":"https://www.proteinatlas.org/search/ALX4"},"hgnc":{"alias_symbol":["FPP","PFM","KIAA1788"],"prev_symbol":["PFM2"]},"alphafold":{"accession":"Q9H161","domains":[{"cath_id":"1.10.10.60","chopping":"224-289","consensus_level":"high","plddt":87.5106,"start":224,"end":289}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9H161","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9H161-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9H161-F1-predicted_aligned_error_v6.png","plddt_mean":57.59},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ALX4","jax_strain_url":"https://www.jax.org/strain/search?query=ALX4"},"sequence":{"accession":"Q9H161","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9H161.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9H161/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9H161"}},"corpus_meta":[{"pmid":"9268572","id":"PMC_9268572","title":"Haploinsufficient phenotypes in Bmp4 heterozygous null mice and modification by mutations in Gli3 and Alx4.","date":"1997","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/9268572","citation_count":243,"is_preprint":false},{"pmid":"9374397","id":"PMC_9374397","title":"Polydactyly and ectopic ZPA formation in Alx-4 mutant mice.","date":"1997","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/9374397","citation_count":170,"is_preprint":false},{"pmid":"11641221","id":"PMC_11641221","title":"Severe nasal clefting and abnormal embryonic apoptosis in Alx3/Alx4 double mutant mice.","date":"2001","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/11641221","citation_count":147,"is_preprint":false},{"pmid":"20140221","id":"PMC_20140221","title":"Performance of epigenetic markers SEPT9 and ALX4 in plasma for detection of colorectal precancerous lesions.","date":"2010","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/20140221","citation_count":147,"is_preprint":false},{"pmid":"12756175","id":"PMC_12756175","title":"Alx1, a member of the Cart1/Alx3/Alx4 subfamily of Paired-class homeodomain proteins, is an essential component of the gene network controlling skeletogenic fate specification in the sea urchin embryo.","date":"2003","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/12756175","citation_count":146,"is_preprint":false},{"pmid":"11137991","id":"PMC_11137991","title":"Haploinsufficiency of the human homeobox gene ALX4 causes skull ossification defects.","date":"2001","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11137991","citation_count":114,"is_preprint":false},{"pmid":"9847249","id":"PMC_9847249","title":"Physical and genetic interactions between Alx4 and Cart1.","date":"1999","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/9847249","citation_count":113,"is_preprint":false},{"pmid":"14512019","id":"PMC_14512019","title":"Progression of calvarial bone development requires Foxc1 regulation of Msx2 and Alx4.","date":"2003","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/14512019","citation_count":105,"is_preprint":false},{"pmid":"19692347","id":"PMC_19692347","title":"ALX4 dysfunction disrupts craniofacial and epidermal development.","date":"2009","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19692347","citation_count":100,"is_preprint":false},{"pmid":"11106354","id":"PMC_11106354","title":"The ALX4 homeobox gene is mutated in patients with ossification defects of the skull (foramina parietalia permagna, OMIM 168500).","date":"2000","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11106354","citation_count":96,"is_preprint":false},{"pmid":"9778501","id":"PMC_9778501","title":"The role of Alx-4 in the establishment of anteroposterior polarity during vertebrate limb development.","date":"1998","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/9778501","citation_count":88,"is_preprint":false},{"pmid":"11017806","id":"PMC_11017806","title":"Haploinsufficiency of ALX4 as a potential cause of parietal foramina in the 11p11.2 contiguous gene-deletion syndrome.","date":"2000","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11017806","citation_count":70,"is_preprint":false},{"pmid":"16319823","id":"PMC_16319823","title":"Enlarged parietal foramina caused by mutations in the homeobox genes ALX4 and MSX2: from genotype to phenotype.","date":"2006","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/16319823","citation_count":57,"is_preprint":false},{"pmid":"9786416","id":"PMC_9786416","title":"Alx-4, a transcriptional activator whose expression is restricted to sites of epithelial-mesenchymal interactions.","date":"1998","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/9786416","citation_count":52,"is_preprint":false},{"pmid":"16039644","id":"PMC_16039644","title":"Function and regulation of Alx4 in limb development: complex genetic interactions with Gli3 and Shh.","date":"2005","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/16039644","citation_count":47,"is_preprint":false},{"pmid":"11696550","id":"PMC_11696550","title":"Alx4 binding to LEF-1 regulates N-CAM promoter activity.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11696550","citation_count":45,"is_preprint":false},{"pmid":"9426253","id":"PMC_9426253","title":"Alx-4: cDNA cloning and characterization of a novel paired-type homeodomain protein.","date":"1997","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/9426253","citation_count":45,"is_preprint":false},{"pmid":"15198690","id":"PMC_15198690","title":"Alx4 and Msx2 play phenotypically similar and additive roles in skull vault differentiation.","date":"2004","source":"Journal of anatomy","url":"https://pubmed.ncbi.nlm.nih.gov/15198690","citation_count":37,"is_preprint":false},{"pmid":"25944620","id":"PMC_25944620","title":"HOXB13 and ALX4 induce SLUG expression for the promotion of EMT and cell invasion in ovarian cancer cells.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/25944620","citation_count":36,"is_preprint":false},{"pmid":"29183346","id":"PMC_29183346","title":"ALX4, an epigenetically down regulated tumor suppressor, inhibits breast cancer progression by interfering Wnt/β-catenin pathway.","date":"2017","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/29183346","citation_count":34,"is_preprint":false},{"pmid":"15968591","id":"PMC_15968591","title":"Genetic interaction of Gli3 and Alx4 during limb development.","date":"2005","source":"The International journal of developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/15968591","citation_count":28,"is_preprint":false},{"pmid":"15569759","id":"PMC_15569759","title":"Malformation of cortical and vascular development in one family with parietal foramina determined by an ALX4 homeobox gene mutation.","date":"2004","source":"AJNR. American journal of neuroradiology","url":"https://pubmed.ncbi.nlm.nih.gov/15569759","citation_count":26,"is_preprint":false},{"pmid":"31132711","id":"PMC_31132711","title":"Epigenetic silencing of ALX4 regulates microcystin-LR induced hepatocellular carcinoma through the P53 pathway.","date":"2019","source":"The Science of the total environment","url":"https://pubmed.ncbi.nlm.nih.gov/31132711","citation_count":25,"is_preprint":false},{"pmid":"22140057","id":"PMC_22140057","title":"Mild nasal malformations and parietal foramina caused by homozygous ALX4 mutations.","date":"2011","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/22140057","citation_count":25,"is_preprint":false},{"pmid":"29028795","id":"PMC_29028795","title":"Alx4 relays sequential FGF signaling to induce lacrimal gland morphogenesis.","date":"2017","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/29028795","citation_count":23,"is_preprint":false},{"pmid":"23401352","id":"PMC_23401352","title":"Vertical transmission of a frontonasal phenotype caused by a novel ALX4 mutation.","date":"2013","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/23401352","citation_count":22,"is_preprint":false},{"pmid":"23942202","id":"PMC_23942202","title":"Genetic analysis of the role of Alx4 in the coordination of lower body and external genitalia formation.","date":"2013","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/23942202","citation_count":21,"is_preprint":false},{"pmid":"11903336","id":"PMC_11903336","title":"Familial case of Potocki-Shaffer syndrome associated with microdeletion of EXT2 and ALX4.","date":"2001","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11903336","citation_count":21,"is_preprint":false},{"pmid":"26918234","id":"PMC_26918234","title":"Methylation pattern of ALX4 gene promoter as a potential biomarker for blood-based early detection of colorectal cancer.","date":"2015","source":"Advanced biomedical research","url":"https://pubmed.ncbi.nlm.nih.gov/26918234","citation_count":20,"is_preprint":false},{"pmid":"31093972","id":"PMC_31093972","title":"Downregulated long noncoding RNA LINC00313 inhibits the epithelial-mesenchymal transition, invasion, and migration of thyroid cancer cells through inhibiting the methylation of ALX4.","date":"2019","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/31093972","citation_count":19,"is_preprint":false},{"pmid":"16916507","id":"PMC_16916507","title":"Loss of Alx4, a stromally-restricted homeodomain protein, impairs mammary epithelial morphogenesis.","date":"2006","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/16916507","citation_count":16,"is_preprint":false},{"pmid":"32856218","id":"PMC_32856218","title":"Overexpression of circ_0001445 decelerates hepatocellular carcinoma progression by regulating miR-942-5p/ALX4 axis.","date":"2020","source":"Biotechnology letters","url":"https://pubmed.ncbi.nlm.nih.gov/32856218","citation_count":13,"is_preprint":false},{"pmid":"20625746","id":"PMC_20625746","title":"HoxB2, HoxB4 and Alx4 genes are downregulated in the cadmium-induced omphalocele in the chick model.","date":"2010","source":"Pediatric surgery international","url":"https://pubmed.ncbi.nlm.nih.gov/20625746","citation_count":12,"is_preprint":false},{"pmid":"24376213","id":"PMC_24376213","title":"Potocki-Shaffer deletion encompassing ALX4 in a patient with frontonasal dysplasia phenotype.","date":"2013","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/24376213","citation_count":12,"is_preprint":false},{"pmid":"31791584","id":"PMC_31791584","title":"miR-1470 regulates cell proliferation and apoptosis by targeting ALX4 in hepatocellular carcinoma.","date":"2019","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/31791584","citation_count":11,"is_preprint":false},{"pmid":"29998114","id":"PMC_29998114","title":"Association of Novel ALX4 Gene Polymorphisms with Antidepressant Treatment Response: Findings from the CO-MED Trial.","date":"2018","source":"Molecular neuropsychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/29998114","citation_count":11,"is_preprint":false},{"pmid":"26076463","id":"PMC_26076463","title":"A 20 bp Duplication in Exon 2 of the Aristaless-Like Homeobox 4 Gene (ALX4) Is the Candidate Causative Mutation for Tibial Hemimelia Syndrome in Galloway Cattle.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26076463","citation_count":11,"is_preprint":false},{"pmid":"24764194","id":"PMC_24764194","title":"Mild nasal clefting may be predictive for ALX4 heterozygotes.","date":"2014","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/24764194","citation_count":11,"is_preprint":false},{"pmid":"19783719","id":"PMC_19783719","title":"Loss of ALX4 expression in epithelial cells and adjacent stromal cells in breast cancer.","date":"2009","source":"Journal of clinical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/19783719","citation_count":10,"is_preprint":false},{"pmid":"16892173","id":"PMC_16892173","title":"Genetic interaction between Lef1 and Alx4 is required for early embryonic development.","date":"2006","source":"The International journal of developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/16892173","citation_count":10,"is_preprint":false},{"pmid":"33781094","id":"PMC_33781094","title":"circKLHL24 Blocks Breast Cancer Development by Regulating the miR-1204/ALX4 Network.","date":"2021","source":"Cancer biotherapy & radiopharmaceuticals","url":"https://pubmed.ncbi.nlm.nih.gov/33781094","citation_count":9,"is_preprint":false},{"pmid":"25673119","id":"PMC_25673119","title":"A novel allele of Alx4 results in reduced Fgf10 expression and failure of eyelid fusion in mice.","date":"2015","source":"Mammalian genome : official journal of the International Mammalian Genome Society","url":"https://pubmed.ncbi.nlm.nih.gov/25673119","citation_count":9,"is_preprint":false},{"pmid":"20552891","id":"PMC_20552891","title":"[Hypermethylation of the CDH1, SEPT9, HLTF and ALX4 genes and their diagnostic significance in colorectal cancer].","date":"2010","source":"Voprosy onkologii","url":"https://pubmed.ncbi.nlm.nih.gov/20552891","citation_count":9,"is_preprint":false},{"pmid":"34900665","id":"PMC_34900665","title":"Circular RNA Circ_0000098 Elevates ALX4 Expression via Adsorbing miR-1204 to Inhibit the Progression of Hepatocellular Carcinoma.","date":"2021","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/34900665","citation_count":7,"is_preprint":false},{"pmid":"29681084","id":"PMC_29681084","title":"Identification of a novel homozygous ALX4 mutation in two unrelated patients with frontonasal dysplasia type-2.","date":"2018","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/29681084","citation_count":7,"is_preprint":false},{"pmid":"33087824","id":"PMC_33087824","title":"Downregulation of microRNA-324-3p inhibits lung cancer by blocking the NCAM1-MAPK axis through ALX4.","date":"2020","source":"Cancer gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/33087824","citation_count":5,"is_preprint":false},{"pmid":"32216639","id":"PMC_32216639","title":"A Novel Missense Variant in the ALX4 Gene Underlies Mild to Severe Frontonasal Dysplasia in a Consanguineous Family.","date":"2020","source":"Genetic testing and molecular biomarkers","url":"https://pubmed.ncbi.nlm.nih.gov/32216639","citation_count":5,"is_preprint":false},{"pmid":"23979902","id":"PMC_23979902","title":"Multiple abnormalities due to a nonsense mutation in the Alx4 gene.","date":"2013","source":"Genetics and molecular research : GMR","url":"https://pubmed.ncbi.nlm.nih.gov/23979902","citation_count":4,"is_preprint":false},{"pmid":"33728725","id":"PMC_33728725","title":"A transgenic Alx4-CreER mouse to analyze anterior limb and nephric duct development.","date":"2021","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/33728725","citation_count":3,"is_preprint":false},{"pmid":"17065792","id":"PMC_17065792","title":"The bovine aristaless-like homeobox 4 (ALX4) as a candidate gene for syndactyly.","date":"2006","source":"Cytogenetic and genome research","url":"https://pubmed.ncbi.nlm.nih.gov/17065792","citation_count":3,"is_preprint":false},{"pmid":"38481039","id":"PMC_38481039","title":"Lineage-specific requirements of Alx4 function in craniofacial and hair development.","date":"2024","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/38481039","citation_count":2,"is_preprint":false},{"pmid":"40410151","id":"PMC_40410151","title":"The ALX4 dimer structure provides insight into how disease alleles impact function.","date":"2025","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/40410151","citation_count":2,"is_preprint":false},{"pmid":"34586326","id":"PMC_34586326","title":"De novo ALX4 variant detected in child with non-syndromic craniosynostosis.","date":"2021","source":"Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas","url":"https://pubmed.ncbi.nlm.nih.gov/34586326","citation_count":2,"is_preprint":false},{"pmid":"33369125","id":"PMC_33369125","title":"Vertical transmission of a large calvarial ossification defect due to heterozygous variants of ALX4 and TWIST1.","date":"2020","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/33369125","citation_count":1,"is_preprint":false},{"pmid":"24941917","id":"PMC_24941917","title":"Solution NMR structures of homeodomains from human proteins ALX4, ZHX1, and CASP8AP2 contribute to the structural coverage of the Human Cancer Protein Interaction Network.","date":"2014","source":"Journal of structural and functional genomics","url":"https://pubmed.ncbi.nlm.nih.gov/24941917","citation_count":1,"is_preprint":false},{"pmid":"37724761","id":"PMC_37724761","title":"Dominant frontonasal dysplasia with ectodermal defects results from increased activity of ALX4.","date":"2023","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/37724761","citation_count":0,"is_preprint":false},{"pmid":"39157323","id":"PMC_39157323","title":"A rare homozygous ALX4 mutation in a Bangladeshi girl with frontonasal dysplasia type-2 (FND2).","date":"2024","source":"Heliyon","url":"https://pubmed.ncbi.nlm.nih.gov/39157323","citation_count":0,"is_preprint":false},{"pmid":"41109384","id":"PMC_41109384","title":"piR-19521 facilitates cancer stem cell-like properties by enhancing ALX4 transcription via an enhancer RNA-like mechanism in colorectal cancer.","date":"2025","source":"International journal of biological macromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/41109384","citation_count":0,"is_preprint":false},{"pmid":"41944225","id":"PMC_41944225","title":"Mir-301b-3p Targets Alx4 to Suppress Cisplatin Sensitivity in Breast Cancer through DNA Damage.","date":"2026","source":"Advanced biology","url":"https://pubmed.ncbi.nlm.nih.gov/41944225","citation_count":0,"is_preprint":false},{"pmid":"27349084","id":"PMC_27349084","title":"[Mother and son with enlarged parietal foramina, persistent fetal vein, and ALX4 mutation].","date":"2016","source":"No to hattatsu = Brain and development","url":"https://pubmed.ncbi.nlm.nih.gov/27349084","citation_count":0,"is_preprint":false},{"pmid":"39298916","id":"PMC_39298916","title":"Correction: A 20 bp Duplication in Exon 2 of the Aristaless-Like Homeobox 4 Gene (ALX4) Is the Candidate Causative Mutation for Tibial Hemimelia Syndrome in Galloway Cattle.","date":"2024","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/39298916","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2024.09.10.612331","title":"Structural and biochemical characterization of the ALX4 dimer reveals novel insights into how disease alleles impact ALX4 function","date":"2024-09-10","source":"bioRxiv","url":"https://doi.org/10.1101/2024.09.10.612331","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.10.11.617797","title":"Deciphering gene regulatory programs in mouse embryonic skin through single-cell multiomics analysis","date":"2024-10-12","source":"bioRxiv","url":"https://doi.org/10.1101/2024.10.11.617797","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.09.02.673690","title":"Genetic analysis of iris pigmentation in Swiss pig breeds identifies a missense  <i>KITLG</i>  variant as a potential causal factor for pale and heterochromatic irises","date":"2025-09-05","source":"bioRxiv","url":"https://doi.org/10.1101/2025.09.02.673690","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":31136,"output_tokens":6428,"usd":0.094914,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":15248,"output_tokens":6096,"usd":0.11432,"stage2_stop_reason":"end_turn"},"total_usd":0.209234,"stage1_batch_id":"msgbatch_0179Z2pxRYBsXi2xADneafRw","stage2_batch_id":"msgbatch_01LaY9ZaVdgjWArcZo9eqQE5","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1997,\n      \"finding\": \"ALX4 (Alx-4) encodes a paired-type homeodomain protein expressed in anterior limb bud mesenchyme; homozygous null mice develop preaxial polydactyly associated with ectopic anterior ZPA formation, as shown by anterior expression of Sonic hedgehog, HoxD13, and FGF-4, establishing ALX4 as a determinant of anterior-posterior positional identity that restricts ZPA formation to the posterior limb bud mesenchyme.\",\n      \"method\": \"Targeted gene disruption (knockout mice), whole-mount in situ hybridization for Shh, HoxD13, FGF-4, HoxB8, Gli3; chromosomal mapping\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean KO with defined cellular phenotype, multiple molecular markers, independently corroborated by other labs\",\n      \"pmids\": [\"9374397\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Alx4 protein is found in nuclear extracts of mouse embryos, consistent with its function as a transcription factor; Northern blot and whole-mount in situ hybridization localize Alx4 expression to craniofacial mesenchyme, first branchial arch, and limb bud during development.\",\n      \"method\": \"Northern blot, whole-mount in situ hybridization, immunoblot of nuclear extracts with anti-Alx4 antibodies\",\n      \"journal\": \"Gene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — direct nuclear localization by fractionation with antibody detection, multiple methods in single lab\",\n      \"pmids\": [\"9426253\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Genetic interaction between Bmp4, Gli3, and Alx4 in anterior digit patterning: double heterozygotes of Bmp4 and Alx4 null alleles display ectopic anterior digits specifically on hindlimbs, placing Alx4 downstream or in parallel with Bmp4 signaling in a multigenic control network for anterior digit formation.\",\n      \"method\": \"Genetic epistasis — double heterozygous mutant mice (Bmp4+/-; Alx4+/-), phenotypic analysis\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean genetic epistasis in double mutant mice, single lab\",\n      \"pmids\": [\"9268572\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"A 16 bp deletion in the homeobox region of Alx-4 in Strong's Luxoid (lstJ) mice causes a frameshift and protein truncation, identifying this as the causative mutation for polydactyly in lstJ mice; chick Alx-4 expression is complementary to Shh, and Shh/FGF application suppresses Alx-4 expression while AER removal experiments indicate a negative feedback loop between Alx-4 and Shh during limb outgrowth, independent of Gli3.\",\n      \"method\": \"Sequence analysis of lstJ allele, chick Alx-4 cloning, bead implantation (Shh/FGF protein application), AER removal surgery, in situ hybridization in polydactylous mutants\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal experimental approaches (mutation identification, protein application, surgical manipulation, mutant analysis) in single study, replicated conceptually across labs\",\n      \"pmids\": [\"9778501\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Alx-4 is a potent transcriptional activator when expressed in cell culture; optimal transcriptional activation requires specific sequences in the N-terminal region and a proline-rich domain downstream of the paired-like homeodomain, but not the paired-tail (C terminus). Alx-4 is expressed in mesenchymal condensations at sites of epithelial-mesenchymal interaction (osteoblast precursors, dermal papilla of hair/whisker follicles, dental papilla, mammary gland mesenchyme).\",\n      \"method\": \"Reporter gene (transcriptional activation) assays in cell culture with deletion constructs; whole-mount in situ hybridization; immunofluorescence\",\n      \"journal\": \"Developmental dynamics : an official publication of the American Association of Anatomists\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reporter assay with domain deletion mutants in cell culture, single lab, multiple deletion constructs tested\",\n      \"pmids\": [\"9786416\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"ALX4 and Cart1 (paired-type homeodomain proteins) form DNA-binding heterodimers in vitro with similar binding activity to palindromic elements; they similarly activate transcription from reporter genes containing high-affinity binding sites in cell culture; double mutant mice show additive/exacerbated craniofacial and limb defects (polydactyly, nasal cartilage fusion failure, split sternum), demonstrating functional redundancy and both unique and shared developmental roles.\",\n      \"method\": \"In vitro DNA binding assay, co-immunoprecipitation/gel-shift (heterodimer formation), reporter gene assay in cell culture, double mutant mouse genetic analysis\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — in vitro reconstitution of heterodimer DNA binding combined with reporter assay and epistatic double-mutant analysis\",\n      \"pmids\": [\"9847249\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Alx4 physically interacts with LEF-1 through a proline-rich domain in the N-terminal region of Alx4 and the HMG-box DNA-binding domain of LEF-1; ALX4 and LEF-1 can bind simultaneously to adjacent sites on the N-CAM promoter, altering N-CAM promoter activity; expression of Alx4 in primary mammary stromal cells decreases endogenous N-CAM protein levels.\",\n      \"method\": \"Co-immunoprecipitation, domain deletion mutants, reporter gene assay on N-CAM promoter, immunoblot of endogenous N-CAM in primary cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal interaction mapped by domain deletions, functional reporter assay, endogenous protein effect confirmed in primary cells, multiple orthogonal methods\",\n      \"pmids\": [\"11696550\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Alx3/Alx4 double mutant mice develop severe nasal clefting and craniofacial defects absent in single mutants; increased apoptosis localized to the frontonasal process in E10.0 double mutants establishes that Alx3 and Alx4 cooperate to suppress apoptosis in outgrowing frontonasal mesenchyme, with functional redundancy in craniofacial development.\",\n      \"method\": \"Generation of Alx3 null (lacZ knock-in) and double mutant mice, histological and anatomical analysis, TUNEL apoptosis assay\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean double KO with defined apoptotic phenotype localized spatiotemporally, multiple methods\",\n      \"pmids\": [\"11641221\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Haploinsufficiency of ALX4 (a paired-related homeodomain transcription factor at 11p11-p12) causes parietal foramina (skull ossification defects) in humans, establishing ALX4 as a dosage-sensitive regulator of calvarial bone formation.\",\n      \"method\": \"Mutation analysis in human patients with parietal foramina; identification of loss-of-function mutations in ALX4; FISH mapping of 11p11.2 deletions\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — human genetic loss-of-function with consistent phenotype, replicated across multiple families and two independent studies (PMID 11137991, 11106354, 11017806)\",\n      \"pmids\": [\"11137991\", \"11106354\", \"11017806\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Foxc1 regulates BMP-mediated induction of Alx4 (and Msx2) in calvarial mesenchyme; BMP induces Alx4 expression in this tissue, and this induction requires the forkhead transcription factor Foxc1; loss of Foxc1 reduces Alx4 and Msx2 expression and impairs osteoprogenitor cell proliferation.\",\n      \"method\": \"Analysis of ch (Foxc1 null) mutant mice, BMP bead implantation, in situ hybridization, BrdU proliferation assay\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function mouse with defined molecular readout, BMP bead gain-of-function, single lab\",\n      \"pmids\": [\"14512019\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Alx4 and Msx2 are partially functionally redundant in skull vault ossification; incremental loss of alleles causes additive exacerbation of skull defects; in Msx2 null mice, Alx4 expression is decreased (but not abolished) in the coronal suture region, and vice versa, indicating mutual regulation; expression of Fgfr1 and Fgfr2 (but not Twist1 or Runx2) is reduced in both single mutants, placing them upstream of Fgfr signaling in the osteogenic network.\",\n      \"method\": \"Alx4/Msx2 double mutant mouse generation and compound genotype analysis, in situ hybridization for multiple markers, alkaline phosphatase staining\",\n      \"journal\": \"Journal of anatomy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — double mutant epistasis with multiple molecular markers, single lab\",\n      \"pmids\": [\"15198690\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"In Alx4 null limb buds, anterior ectopic expression of Fgf4 and Hoxd13 occurs independently of SHH signaling at early stages, while later polydactyly requires SHH; Gli3-dependent and Gli3-independent modules control Alx4 expression in the limb bud (total absence of reporter in Gli3-/- background; expansion in Shh-/- background), and loss of the severe polydactyly in Gli3-/-;Alx4-/- double mutants shows that this polydactyly requires Alx4 function.\",\n      \"method\": \"Alx4/Gli3 double mutant analysis, reporter construct expression analysis in Shh-/- and Gli3-/- backgrounds, in situ hybridization\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — epistasis with multiple single and double mutants, reporter construct analysis, multiple orthogonal methods, consistent with independent study (PMID 15968591)\",\n      \"pmids\": [\"16039644\", \"15968591\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Alx4 is expressed in mammary stromal cells adjacent to terminal end buds during puberty; its expression is induced by 17β-estradiol in stromal cells; loss of Alx4 causes defective ductal morphogenesis (delayed development, distorted duct size, reduced branching). The morphogenic defect is stromal-cell-autonomous: Alx4-deficient stromal cells combined with wild-type epithelial cells recapitulate the defect, but wild-type stromal cells rescue Alx4-deficient epithelial cells. MMP2 is increased 40% and MMP9 decreased 50% in Alx4-deficient mammary stromal cells.\",\n      \"method\": \"Alx4 null mouse analysis, mammary fat pad transplantation (stromal/epithelial mixing experiments), whole-mount analysis, RT-PCR for HGF/MMP2/MMP3/MMP9\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — cell-autonomous stromal function established by fat pad transplantation (reconstitution experiment), multiple molecular readouts, single lab with rigorous cell-mixing design\",\n      \"pmids\": [\"16916507\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Genetic interaction between Lef1 and Alx4 is required for early embryonic development; compound Lef1-/-/Alx4lstD/lstD double mutant mice die by E9.5 (whereas single mutants survive), with defective vasculogenesis in embryonic and extraembryonic tissues, genetically confirming the in vitro Alx4–LEF-1 interaction.\",\n      \"method\": \"Double mutant mouse generation (Lef1-/-/Alx4lstD/lstD), embryo analysis, PECAM staining for vasculature\",\n      \"journal\": \"The International journal of developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic confirmation of biochemical interaction with defined lethal phenotype, single lab\",\n      \"pmids\": [\"16892173\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"A homozygous nonsense mutation in ALX4 (p.R265X) truncating the homeodomain and paired-tail domain produces a non-functional protein (mRNA is stable; no NMD); in patient skin, there is a hypomorphic interfollicular epidermis with reduced suprabasal layers, impaired interfollicular epidermal differentiation, and altered hair follicle differentiation, establishing ALX4 as required for craniofacial, skin, and hair follicle development.\",\n      \"method\": \"Homozygosity mapping, mutation identification, RT-PCR (NMD testing), skin biopsy histology and differentiation marker analysis\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — human loss-of-function with direct tissue analysis of downstream molecular phenotype, single family\",\n      \"pmids\": [\"19692347\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"NMR solution structures of the ALX4 homeodomain were determined, providing structural coverage of the DNA-binding domain.\",\n      \"method\": \"Solution NMR structure determination\",\n      \"journal\": \"Journal of structural and functional genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — NMR structure solved but no functional validation in same study\",\n      \"pmids\": [\"24941917\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"HOXB13 and ALX4 form a protein complex in ovarian cancer cells; exogenous expression of either promotes EMT and invasion, while depletion suppresses invasion and reverses EMT; both HOXB13 and ALX4 promote SLUG expression, and SLUG is required for their pro-EMT and pro-invasion effects.\",\n      \"method\": \"Co-immunoprecipitation (complex formation), overexpression and siRNA knockdown, invasion assays, SLUG knockdown rescue experiments, immunoblot\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP for complex, loss- and gain-of-function with epistatic rescue using SLUG knockdown, single lab\",\n      \"pmids\": [\"25944620\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"ALX4 suppresses the Wnt/β-catenin pathway by promoting GSK3β-dependent phosphorylation and degradation of β-catenin in breast cancer cells; ectopic ALX4 expression inhibits cell proliferation and metastasis in vitro and in vivo.\",\n      \"method\": \"Luciferase reporter assay (Wnt/β-catenin), Western blot for phospho-β-catenin/total β-catenin, overexpression in cancer cell lines, nude mouse xenograft\",\n      \"journal\": \"Journal of experimental & clinical cancer research : CR\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reporter assay plus phosphorylation western blot, in vivo validation, single lab\",\n      \"pmids\": [\"29183346\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Alx4 directly controls Fgf10 expression in periocular mesenchyme by binding a conserved intronic enhancer element of Fgf10 (conserved in terrestrial but not aquatic animals); Alx4 expression in the neural crest requires Shp2-mediated FGF signaling; loss of Alx4/ALX4 causes lacrimal gland aplasia in mouse and human, positioning Alx4 as a relay in an FGF-Shp2-FGF signaling cascade.\",\n      \"method\": \"ChIP/reporter assay (Alx4 binding to Fgf10 intronic element), conditional knockout mice (Shp2 in neural crest), in situ hybridization, human patient genetic analysis\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct binding to Fgf10 enhancer element shown, conditional KO, conservation analysis, human genetic validation, multiple orthogonal methods\",\n      \"pmids\": [\"29028795\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Loss of Alx4 causes reduced Fgf10 expression in eyelid mesenchyme and failure of eyelid fusion in mice; reduced Fgf10 is accompanied by a decreased number of periderm cells expressing phospho-c-Jun, establishing that Alx4 regulates eyelid fusion through control of Fgf10 expression.\",\n      \"method\": \"Novel Alx4 spontaneous allele characterization, in situ hybridization for Fgf10, immunostaining for phospho-c-Jun in periderm\",\n      \"journal\": \"Mammalian genome : official journal of the International Mammalian Genome Society\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function with defined molecular readout (Fgf10 and phospho-c-Jun), single lab\",\n      \"pmids\": [\"25673119\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"A frameshift insertion in ALX4 (c.985_986insGTGC, p.Pro329Argfs*115) that elongates the protein tail domain causes dominant frontonasal dysplasia with ectodermal defects; using a reporter assay, the elongated ALX4 protein shows increased transcriptional activity (gain-of-function); patient keratinocytes show altered expression of Wnt/β-catenin pathway genes, consistent with ALX4 negatively regulating this pathway.\",\n      \"method\": \"Whole-exome sequencing, reporter assay for ALX4 transcriptional activity, Wnt/β-catenin target gene expression in patient keratinocytes\",\n      \"journal\": \"American journal of medical genetics. Part A\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reporter assay showing gain-of-function, patient cell molecular analysis, single family\",\n      \"pmids\": [\"37724761\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Crystal/structural analysis of the ALX4 dimer reveals that ALX4 binds a TAAT-NNN-ATTA palindromic dimer site; seven residues participate in dimer binding (conserved across Paired-like family but not other homeodomain proteins); the two ALX4 molecules within the dimer use distinct residues to form asymmetric protein-protein and protein-DNA contacts; ALX4 cooperativity (dimerization) is required for transcriptional activation; disease variants cause distinct molecular defects including loss of cooperativity; ALX4 binds this motif independently of TWIST1 in cranial neural crest cells.\",\n      \"method\": \"Protein structure determination (crystal/cryo), in vitro DNA binding assays with mutant ALX4 variants, reporter gene assay in cranial neural crest cells, active-site mutagenesis\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — structure solved with functional validation (mutagenesis, reporter assay, disease variant stratification), multiple orthogonal methods in single rigorous study\",\n      \"pmids\": [\"40410151\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Tissue-specific Cre-mediated inactivation of Alx4 in cranial neural crest recapitulates craniofacial defects of Alx4-null mice; Alx4 inactivation in cranial neural crest causes restricted hair loss over anterior skull, while inactivation in cranial mesoderm does not affect hair, revealing that Alx4 plays partly redundant roles in multiple lineages during hair follicle development.\",\n      \"method\": \"Conditional knockout mice (Alx4f/f with lineage-specific Cre lines for neural crest and cranial mesoderm), phenotypic analysis\",\n      \"journal\": \"Developmental dynamics : an official publication of the American Association of Anatomists\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO in defined lineages with specific phenotypic readout, single lab\",\n      \"pmids\": [\"38481039\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Alx4 is required for normal genital tubercle (GT) development; Alx4 loss-of-function (Alx4Lst/Lst) results in hypoplasia of the dorsal GT and reduced Fibronectin expression; cell migration from infra-umbilical mesenchyme toward the dorsal GT is impaired; augmented Hh signaling-related gene expression in Alx4 mutants, and combinatorial mutant analysis places Alx4 in a genetic interaction with Shh and Gli3 during GT formation.\",\n      \"method\": \"Alx4Lst/Lst mutant and combinatorial mutant analysis (with Shh, Gli3), tissue labeling for cell migration, in situ hybridization for Hh pathway genes, immunostaining for Fibronectin\",\n      \"journal\": \"European journal of human genetics : EJHG\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis with multiple combinatorial mutants, cell migration labeling, molecular readout, single lab\",\n      \"pmids\": [\"23942202\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ALX4 is a paired-like homeodomain transcription factor that forms cooperative homodimers (and heterodimers with Cart1/ALX3) binding palindromic TAAT-NNN-ATTA DNA motifs through asymmetric protein-protein and protein-DNA contacts; it activates transcription via N-terminal proline-rich and homeodomain sequences, physically interacts with LEF-1 to regulate target promoters such as N-CAM, directly binds an Fgf10 intronic enhancer to control lacrimal gland and eyelid development downstream of FGF-Shp2 signaling, suppresses the Wnt/β-catenin pathway through GSK3β-dependent β-catenin degradation, and restricts Sonic hedgehog/ZPA activity to the posterior limb bud mesenchyme through a negative feedback loop with Shh—with haploinsufficiency causing parietal foramina and biallelic loss causing frontonasal dysplasia, alopecia, and craniofacial defects in humans.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"ALX4 is a paired-like homeodomain transcription factor that controls anterior–posterior patterning and morphogenesis of the developing limb, craniofacial skeleton, skin, and glandular tissues by regulating mesenchymal gene expression [#0, #4]. As a nuclear transcriptional activator, it acts through N-terminal and proline-rich sequences flanking its homeodomain, while the paired-tail is dispensable for activation [#1, #4]. DNA binding is cooperative: ALX4 engages a palindromic TAAT-NNN-ATTA dimer site, with the two molecules making asymmetric protein–protein and protein–DNA contacts, and this dimerization is required for transcriptional activation [#21]; it also forms DNA-binding heterodimers with the related factor Cart1 that share target sites and developmental roles [#5]. ALX4 partners with LEF-1 through its N-terminal proline-rich region, co-occupies adjacent sites on the N-CAM promoter, and represses N-CAM, a functional interaction genetically required for embryonic vasculogenesis [#6, #13]. In the limb bud, Alx4 is expressed in anterior mesenchyme and restricts ectopic posterior signaling: its loss causes anterior ectopic Shh, Fgf4, and Hoxd13 expression and preaxial polydactyly, operating in a negative-feedback relationship with Shh and through both Gli3-dependent and Gli3-independent modules [#0, #3, #11]. ALX4 sits within BMP- and FGF-driven signaling networks—its calvarial expression is induced by BMP via Foxc1 and is partially redundant with Msx2 upstream of Fgfr signaling [#9, #10]—and it relays FGF-Shp2 signaling by directly binding a conserved Fgf10 intronic enhancer to drive lacrimal gland and eyelid development [#18, #19]. ALX4 additionally suppresses Wnt/β-catenin signaling by promoting GSK3β-dependent β-catenin phosphorylation and degradation [#17, #20]. In humans, ALX4 haploinsufficiency causes parietal foramina, while biallelic loss-of-function and gain-of-function frameshift alleles cause frontonasal dysplasia with skin, hair, and craniofacial defects [#8, #14, #20].\",\n  \"teleology\": [\n    {\n      \"year\": 1997,\n      \"claim\": \"Established ALX4 as a determinant of limb anterior–posterior identity, answering whether an anterior mesenchymal homeodomain factor restricts posterior signaling-center formation.\",\n      \"evidence\": \"Targeted knockout mice with molecular marker in situ hybridization (Shh, HoxD13, FGF-4)\",\n      \"pmids\": [\"9374397\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct transcriptional targets in limb not identified\", \"Mechanism of ZPA restriction not resolved at molecular level\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Confirmed nuclear localization and developmental expression domains, supporting a transcription factor role across craniofacial and limb mesenchyme.\",\n      \"evidence\": \"Nuclear extract immunoblot, Northern blot, whole-mount in situ hybridization in mouse embryos\",\n      \"pmids\": [\"9426253\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No target genes identified\", \"No DNA-binding specificity defined at this stage\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Placed Alx4 within a multigenic anterior digit-patterning network downstream of or parallel to BMP signaling.\",\n      \"evidence\": \"Bmp4/Alx4 double heterozygous mouse genetic epistasis\",\n      \"pmids\": [\"9268572\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Biochemical link between Bmp4 and Alx4 not defined\", \"Direction of regulation (downstream vs parallel) unresolved\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Defined the negative feedback loop between Alx4 and Shh in limb outgrowth and identified the causative lstJ mutation, distinguishing the feedback from Gli3 control.\",\n      \"evidence\": \"lstJ allele sequencing, chick Shh/FGF bead implantation, AER removal surgery, in situ hybridization\",\n      \"pmids\": [\"9778501\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular mediators of Shh suppression of Alx4 unknown\", \"Whether feedback is direct or indirect not established\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Mapped the transcriptional activation determinants of ALX4 to the N-terminal and proline-rich regions, clarifying domain architecture for activator function.\",\n      \"evidence\": \"Reporter assays with deletion constructs in cell culture; expression analysis at epithelial–mesenchymal interfaces\",\n      \"pmids\": [\"9786416\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Coactivators recruited by N-terminal/proline-rich domains not identified\", \"Native target promoters not tested\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Demonstrated ALX4–Cart1 heterodimer formation and shared DNA-binding/activation properties, with double mutants revealing functional redundancy in craniofacial and limb development.\",\n      \"evidence\": \"In vitro DNA binding, gel-shift/Co-IP, reporter assays, double mutant mouse analysis\",\n      \"pmids\": [\"9847249\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo distribution of homo- vs heterodimers unknown\", \"Distinct vs shared target genes not enumerated\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Identified LEF-1 as a direct ALX4 partner and N-CAM as a regulated target, linking ALX4 to promoter co-occupancy and gene repression.\",\n      \"evidence\": \"Co-IP with domain mapping, N-CAM promoter reporter, endogenous N-CAM immunoblot in primary stromal cells\",\n      \"pmids\": [\"11696550\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether the interaction modulates Wnt signaling at this stage not addressed\", \"Genome-wide co-targets unknown\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Showed Alx3/Alx4 cooperate to suppress apoptosis in frontonasal mesenchyme, establishing redundancy in craniofacial outgrowth.\",\n      \"evidence\": \"Alx3 null and Alx3/Alx4 double mutant mice, histology, TUNEL assay\",\n      \"pmids\": [\"11641221\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Pro-survival target genes not identified\", \"Mechanism linking ALX factors to apoptosis suppression unknown\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Established ALX4 as a dosage-sensitive human gene, with haploinsufficiency causing parietal foramina.\",\n      \"evidence\": \"Human mutation analysis, loss-of-function identification, FISH mapping across multiple families\",\n      \"pmids\": [\"11137991\", \"11106354\", \"11017806\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Calvarial target genes not identified\", \"Threshold for dosage sensitivity not defined\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Positioned Alx4 downstream of BMP and Foxc1 in calvarial osteoprogenitor induction.\",\n      \"evidence\": \"Foxc1 null mice, BMP bead implantation, in situ hybridization, BrdU assay\",\n      \"pmids\": [\"14512019\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether Foxc1 directly regulates the Alx4 promoter not shown\", \"Direct BMP-responsive elements not mapped\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Defined partial redundancy and mutual regulation between Alx4 and Msx2, placing them upstream of Fgfr signaling in skull ossification.\",\n      \"evidence\": \"Alx4/Msx2 compound mutant mice, multi-marker in situ hybridization, alkaline phosphatase staining\",\n      \"pmids\": [\"15198690\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct vs indirect mutual regulation unresolved\", \"Whether Fgfr1/2 are direct targets not established\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Dissected Gli3-dependent and Gli3-independent control of Alx4, showing early ectopic Fgf4/Hoxd13 is SHH-independent while polydactyly requires Alx4.\",\n      \"evidence\": \"Alx4/Gli3 double mutants, reporter analysis in Shh-/- and Gli3-/- backgrounds, in situ hybridization\",\n      \"pmids\": [\"16039644\", \"15968591\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Enhancer elements mediating Gli3-dependent control not mapped\", \"Mechanism of SHH-independent ectopic gene expression unknown\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Established a stromal-cell-autonomous role for Alx4 in mammary ductal morphogenesis, induced by estradiol and linked to MMP balance.\",\n      \"evidence\": \"Alx4 null analysis, fat pad transplantation/cell mixing, RT-PCR for MMPs/HGF\",\n      \"pmids\": [\"16916507\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether MMP2/MMP9 are direct transcriptional targets unknown\", \"Estradiol-to-Alx4 induction mechanism not defined\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Genetically validated the Alx4–LEF-1 interaction in vivo, showing it is required for embryonic vasculogenesis.\",\n      \"evidence\": \"Lef1-/-/Alx4lstD/lstD double mutant embryos, PECAM staining\",\n      \"pmids\": [\"16892173\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Vascular target genes of the Alx4–LEF-1 complex not identified\", \"Cell type driving the vascular defect not pinpointed\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Linked biallelic ALX4 loss to a broader human phenotype including skin and hair follicle defects, defining tissue-level requirements.\",\n      \"evidence\": \"Homozygosity mapping, p.R265X mutation identification, NMD testing, skin biopsy differentiation analysis\",\n      \"pmids\": [\"19692347\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Epidermal target genes not identified\", \"Single family limits genotype–phenotype generalization\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Extended Alx4 function to genital tubercle development, linking it to Fibronectin-dependent cell migration and Hh/Gli3 interaction.\",\n      \"evidence\": \"Alx4Lst/Lst and combinatorial mutants, cell migration labeling, Fibronectin immunostaining, Hh-pathway in situ\",\n      \"pmids\": [\"23942202\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether Fibronectin is a direct target unknown\", \"Mechanism of migration control not defined\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Identified Fgf10 as the effector through which Alx4 controls eyelid fusion, connecting it to periderm phospho-c-Jun signaling.\",\n      \"evidence\": \"Spontaneous Alx4 allele, Fgf10 in situ hybridization, phospho-c-Jun immunostaining\",\n      \"pmids\": [\"25673119\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct binding to Fgf10 regulatory elements not shown in this study\", \"Link to phospho-c-Jun mechanistically indirect\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Revealed an oncogenic context where ALX4 complexes with HOXB13 to drive EMT and invasion via SLUG.\",\n      \"evidence\": \"Co-IP, overexpression/siRNA, invasion assays, SLUG knockdown rescue in ovarian cancer cells\",\n      \"pmids\": [\"25944620\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether SLUG is a direct ALX4/HOXB13 target not shown\", \"Reciprocal Co-IP validation not described\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Demonstrated direct ALX4 binding to a conserved Fgf10 intronic enhancer downstream of FGF-Shp2 signaling, defining ALX4 as a signaling relay for lacrimal gland development.\",\n      \"evidence\": \"ChIP/reporter assay, neural-crest Shp2 conditional knockout, in situ hybridization, human genetic analysis\",\n      \"pmids\": [\"29028795\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Other direct enhancer targets not catalogued\", \"Cofactors at the Fgf10 enhancer not identified\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Defined ALX4 as a suppressor of Wnt/β-catenin signaling via GSK3β-dependent β-catenin degradation, with tumor-suppressive consequences.\",\n      \"evidence\": \"Wnt reporter assay, phospho-β-catenin western blot, overexpression, nude mouse xenograft\",\n      \"pmids\": [\"29183346\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which a transcription factor promotes GSK3β-dependent degradation not resolved\", \"Direct vs indirect effect on the destruction complex unknown\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Identified a gain-of-function tail-elongating frameshift causing dominant frontonasal dysplasia and confirmed ALX4 negatively regulates Wnt/β-catenin in patient cells.\",\n      \"evidence\": \"Whole-exome sequencing, transcriptional reporter assay, Wnt target gene expression in patient keratinocytes\",\n      \"pmids\": [\"37724761\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of tail-domain-driven hyperactivation not defined\", \"Single family limits generalization\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Resolved the structural basis of cooperative ALX4 dimer binding to the TAAT-NNN-ATTA palindrome and showed dimerization is required for activation, stratifying disease variants by molecular defect.\",\n      \"evidence\": \"Protein structure determination, mutant in vitro DNA binding, reporter assays in cranial neural crest cells, mutagenesis\",\n      \"pmids\": [\"40410151\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo genome-wide binding map not established\", \"Functional consequences of each disease variant not tested in animals\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Used lineage-specific inactivation to assign ALX4 craniofacial and hair phenotypes primarily to cranial neural crest, revealing partly redundant roles across lineages.\",\n      \"evidence\": \"Conditional Alx4 knockout with neural crest and cranial mesoderm Cre lines, phenotypic analysis\",\n      \"pmids\": [\"38481039\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Lineage-specific target genes not identified\", \"Redundant factors in each lineage not defined\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The genome-wide direct target repertoire of ALX4 and the molecular basis by which it links DNA-binding to Wnt destruction-complex activity and FGF/SHH feedback remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No comprehensive in vivo ChIP-seq target map\", \"Mechanism connecting ALX4 to GSK3β-dependent β-catenin degradation undefined\", \"How dimer cooperativity is tuned by partners (LEF-1, Cart1, HOXB13) across tissues unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 4, 5, 21]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [5, 21, 18]},\n      {\"term_id\": \"GO:0000981\", \"supporting_discovery_ids\": [4]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [1]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [0, 7, 18, 22]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [4, 6, 21]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [3, 11, 17, 18]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [8, 14, 20]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"CART1\", \"LEF1\", \"HOXB13\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}